Elizabeth H. Golembiewski, Andrea E. Garcia Bautista, Eric C Polley, Guillermo E Umpierrez, Rodolfo J. Galindo, Juan P. Brito, Victor M. Montori, Janet P. Gockerman, Michael Tesulov, Bertina Labatte, Mindy M. Mickelson, Rozalina G. McCoy
{"title":"Outomes and Attributes Patients Value When Choosing Glucose-Lowering Medications: A Mixed-Methods Study","authors":"Elizabeth H. Golembiewski, Andrea E. Garcia Bautista, Eric C Polley, Guillermo E Umpierrez, Rodolfo J. Galindo, Juan P. Brito, Victor M. Montori, Janet P. Gockerman, Michael Tesulov, Bertina Labatte, Mindy M. Mickelson, Rozalina G. McCoy","doi":"10.2337/cd23-0042","DOIUrl":null,"url":null,"abstract":"This mixed-methods study sought to identify pharmacotherapy preferences among 40 noninsulin-treated adults with type 2 diabetes receiving care at two U.S. health care systems. Participants ranked by relative importance various health outcomes and medication attributes and then contextualized their rankings. Most participants ranked blindness (63%), death (60%), heart attack (48%), and heart failure (48%) as the most important health outcomes and glucose-lowering efficacy (68%) as the most important medication attribute, followed by oral administration (45%) and lack of gastrointestinal side effects (38%).","PeriodicalId":504780,"journal":{"name":"Clinical Diabetes","volume":"5 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2337/cd23-0042","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This mixed-methods study sought to identify pharmacotherapy preferences among 40 noninsulin-treated adults with type 2 diabetes receiving care at two U.S. health care systems. Participants ranked by relative importance various health outcomes and medication attributes and then contextualized their rankings. Most participants ranked blindness (63%), death (60%), heart attack (48%), and heart failure (48%) as the most important health outcomes and glucose-lowering efficacy (68%) as the most important medication attribute, followed by oral administration (45%) and lack of gastrointestinal side effects (38%).
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
